Pharmaceuticals
Regu-Mate®
(altrenogest)
Indications

Regu-Mate® (altrenogest) Solution 0.22% is indicated to suppress estrus in mares. Suppression of estrus allows for a predictable occurrence of estrus following drug withdrawal. This facilitates the attainment of regular cyclicity during the transition from winter anestrus to the physiological breeding season. Suppression of estrus will also facilitate management of prolonged estrus conditions. Suppression of estrus may be used to facilitate scheduled breeding during the physiological breeding season.

The Science of Trusted

  • Trust genuine Regu-Mate® (altrenogest) for proven palatability, bioavailability and efficacy in every dose
  • The only FDA-approved altrenogest with more than 20 million doses sold
  • Delivers safe, predictable control over a mare's reproductive cycle and reduces undesirable mood and behavioral changes
  • 15-day treatment regimen lets performance mares compete at their best
  • Strategic use helps accommodate mare's performance schedule
  • Easy to administer with Regu-Mate dosing device
  • Regu-Mate® is contraindicated for use in mares having a previous or current history of uterine inflammation. When treatment is discontinued, mares exhibiting regular estrous cycles return to estrus within 4 to 5 days following treatment and continue to cycle normally. Pregnant women or women who suspect they are pregnant should not handle Regu-Mate®.

Talk to your veterinarian about proper use and safe handling of Regu-Mate®. Avoid skin contact. Always wear protective gloves when administering Regu-Mate®. This product is contraindicated for use in mares with a previous or current history of uterine inflammation. Pregnant women, or women who suspect they are pregnant, should not handle this product. For complete product information, see accompanying product insert.

Science

Additional Resources

Administration

IMPORTANT SAFETY INFORMATION:

Regu-Mate® is contraindicated for use in mares having a previous or current history of uterine inflammation. Natural or synthetic gestagen therapy may exacerbate existing low-grade or "smoldering" uterine inflammation into a fulminating uterine infection in some instances. Do not use in horses intended for human consumption. Direct contact with skin must be avoided and protective gloves must be worn when handling this product. Pregnant women or women who suspect they are pregnant should not handle Regu-Mate®. Women of child bearing age should exercise extreme caution when handling this product as it is readily absorbed through skin and could lead to a disruption of the menstrual cycle or prolongation of pregnancy. Direct contact with the skin should be avoided and accidental spillage on the skin should be washed off immediately with soap and water. Keep out of the reach of children. For complete safety information, refer to the product label.